These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3286291)
21. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders. Saffan D; Seibel MM Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681 [TBL] [Abstract][Full Text] [Related]
22. Ovulation induction in clomiphene nonresponsive patients: the place of pulsatile gonadotropin-releasing hormone in clinical practice. Molloy BG; Hancock KW; Glass MR Fertil Steril; 1985 Jan; 43(1):26-33. PubMed ID: 3917407 [TBL] [Abstract][Full Text] [Related]
23. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome. Polson DW; Mason HD; Franks S Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444 [TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Rouzi AA; Ardawi MS Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222 [TBL] [Abstract][Full Text] [Related]
25. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
26. The relationship between the pituitary response to luteinizing hormone-releasing hormone and the ovulatory response to clomiphene citrate. Feore JC; Taymor ML Fertil Steril; 1976 Nov; 27(11):1240-5. PubMed ID: 789117 [TBL] [Abstract][Full Text] [Related]
27. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study. Graña-Barcia M; Liz-Lestón J; Lado-Abeal J Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586 [TBL] [Abstract][Full Text] [Related]
28. The use of synthetic luteinizing hormone-releasing hormone in induction of ovulation. Acosta AA; Buttram VC; Malinak LR; Besch PK; Franklin RR Fertil Steril; 1975 Dec; 26(12):1173-7. PubMed ID: 803167 [TBL] [Abstract][Full Text] [Related]
29. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487 [TBL] [Abstract][Full Text] [Related]
30. The combination of gonadotrophin-releasing hormone (GnRH) antagonist and pulsatile GnRH normalizes luteinizing hormone secretion in polycystic ovarian disease but fails to induce follicular maturation. Dubourdieu S; Le Nestour E; Spitz IM; Charbonnel B; Bouchard P Hum Reprod; 1993 Dec; 8(12):2056-60. PubMed ID: 8150903 [TBL] [Abstract][Full Text] [Related]
31. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling. Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485 [TBL] [Abstract][Full Text] [Related]
32. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. Homburg R; Eshel A; Armar NA; Tucker M; Mason PW; Adams J; Kilborn J; Sutherland IA; Jacobs HS BMJ; 1989 Mar; 298(6676):809-12. PubMed ID: 2496866 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease. Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482 [TBL] [Abstract][Full Text] [Related]
34. Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol. Budinetz TH; Benadiva CA; Griffin DW; Engmann LL; Nulsen JC; DiLuigi AJ Fertil Steril; 2015 Mar; 103(3):675-9. PubMed ID: 25577463 [TBL] [Abstract][Full Text] [Related]
35. Preoperative luteinizing hormone levels predict the ovulatory response to laparoscopic ovarian drilling in patients with clomiphene citrate-resistant polycystic ovary syndrome. Hayashi H; Ezaki K; Endo H; Urashima M Gynecol Endocrinol; 2005 Dec; 21(6):307-11. PubMed ID: 16390777 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [TBL] [Abstract][Full Text] [Related]
37. Conventional dose intravenous pulsatile GnRH therapy does not induce ovulation in polycystic ovarian disease. Wilson JM; Traub AI; Sheridan B; Thompson W; Atkinson AB Acta Endocrinol (Copenh); 1988 Mar; 117(3):289-94. PubMed ID: 2968035 [TBL] [Abstract][Full Text] [Related]
38. Ovulatory disorders in women with polycystic ovary syndrome. Franks S; Adams J; Mason H; Polson D Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879 [TBL] [Abstract][Full Text] [Related]
39. Use of synthetic luteinizing hormone-releasing hormone in induction of ovulation in amenorrheic patients. Huang KE Fertil Steril; 1975 Aug; 26(8):796-801. PubMed ID: 1098942 [TBL] [Abstract][Full Text] [Related]
40. [Clinical effects of pulsatile LH-RH administration on ovulation induction for women with various type of amenorrhea]. Mizunuma H; Obara M; Yamada K; Ibuki Y Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):253-8. PubMed ID: 2185321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]